Keeping you up to date on your investment
Follow the heartbeat of our mission as we strive to transform the lives of heart failure patients. Join our journey to redefine the landscape of cardiac health and help create a brighter future for patients worldwide.
Share price chart
Presentations & Webinars
SEC Filings
Date
Announcement
Download
April 11, 2025
Annual Report 2024
April 1, 2025
Preliminary proxy statement - Schedule 14A
April 1, 2025
Initial statement of beneficial ownership of securities
March 24, 2025
Annual report 2024 [10-K]
March 20, 2025
Current report Open document 8-K
ASX Announcements
Date
Announcement
Download
April 14, 2025
Corporate Governance Statement
April 14, 2025
Annual Report 2024
April 14, 2025
Notice of 2025 Annual Meeting
April 14, 2025
FDA Approval of WiSE CRT System
April 4, 2025
Appendix 3G Notification of issue, conversion or payment up of unquoted equity securities
News
Corporate governance
The EBR Board of Directors is responsible to shareholders for the overall governance and performance of the company.
The roles and responsibilities of the Board of Directors, Board Committees, management and operating subsidiaries have been established through Board-approved charters and formal delegations of authority.
The Board and Committee Charters and the Delegations of Authority provide the basis for the good governance of the company and operate in conjunction with the Constitution of the company, the Corporations Act and other relevant laws.
See entire list
- Charters
- Code of Business Conduct and Ethics (PDF)
- Securities Trading Policy (PDF)
- Reg FD Corporate Disclosure Policy (PDF)
- Risk Management Policy (PDF)
- Diversity Policy (PDF)
- Whistleblower Policy (PDF)
- Anti-Bribery and Anti-Corruption Policy (PDF)
- Corporate Governance Statement (PDF)
- Related Persons Approval Policy (PDF)
- Continuous Disclosure Policy (PDF)